Showing results (121-130 of 185) with videos related to
Sort By:
Pageof 19
The American Journal of Gastroenterology|February 9, 2023
Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic ReviewSudheer K Vuyyuru, Florian Rieder, Virginia Solitano, et al.Digestive Diseases and Sciences|April 29, 2023
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched StudyEmily C L Wong, Shahin Merat, Cristina Monaco, et al.Journal of Crohn'S & Colitis|September 20, 2024
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel DiseaseSunil Samnani, Emily C L Wong, Hasan Hamam, et al.Journal of Gastroenterology and Hepatology|May 21, 2021
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysisNeeraj Narula, Emily C L Wong, Raed AlRamdan, et al.The American Journal of Gastroenterology|August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC TrialNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.Journal of Clinical Gastroenterology|October 13, 2022
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.Inflammatory Bowel Diseases|July 26, 2022
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's DiseaseEmily C L Wong, Arif Yusuf, Jagoda Pokryszka, et al.The American Journal of Gastroenterology|April 3, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 TrialShane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano, et al.Alimentary Pharmacology & Therapeutics|November 4, 2025
Meta-Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel DiseasePurab Patel, Peter Belesiotis, Nitin Shiv Rai, et al.Journal of Crohn'S & Colitis|October 19, 2021
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's DiseaseNeeraj Narula, Emily C L Wong, Jean-Frederic Colombel, et al.Pageof 19